Literature DB >> 7693407

Longitudinal changes of plasma pancreatic enzymes and hormones in experimental pancreatolithiasis in dogs.

T Hayakawa1, T Kondo, T Shibata, M Kitagawa, H Sobajima, Y Sakai, H Ishiguro, Y Nakae, M Tanikawa, S Naruse.   

Abstract

Plasma pancreatic enzymes and hormones were longitudinally observed after producing partial obstruction of the major pancreatic duct in dogs to study an initial state of chronic pancreatitis or pancreatolithiasis. Fasting plasma immunoreactive cationic trypsin was elevated during the first six months and then decreased in a subgroup with pancreatic calculi, marked fibrosis, or duct dilatation when compared with the corresponding opposite at the end of the 12-month period. Similar but less prominent changes were found in fasting plasma immunoreactive pancreatic polypeptide (IRPP). Plasma amylase, glucose, or immunoreactive insulin or glucagon (IRG) show no significant variation. Plasma IRG and IRPP responses to intravenous insulin were reduced in the subgroups with marked pancreatic changes towards the end of the 12-month period. These results suggest that plasma pancreatic enzymes and hormones remain elevated as long as pancreatic damage is mild and then start to decline as the damage progresses in chronic pancreatitis or pancreatolithiasis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693407     DOI: 10.1007/bf01297091

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Glucose tolerance and insulin secretion in rabbits and dogs after ligation of the pancreatic ducts.

Authors:  W Heptner; H P Neubauer; R Schleyerbach
Journal:  Diabetologia       Date:  1974-06       Impact factor: 10.122

2.  Radioimmunoassay of extracted glucagon compared with three non-extraction assays.

Authors:  H von Schenck; O R Nilsson
Journal:  Clin Chim Acta       Date:  1981-01-22       Impact factor: 3.786

3.  Impaired pancreatic polypeptide secretion in chronic pancreatitis.

Authors:  A Sive; A I Vinik; S Van Tonder; A Lund
Journal:  J Clin Endocrinol Metab       Date:  1978-09       Impact factor: 5.958

4.  Can plasma human pancreatic polypeptide be used to detect diseases of the exocrine pancreas?

Authors:  M B Koch; V L Go; E P DiMagno
Journal:  Mayo Clin Proc       Date:  1985-04       Impact factor: 7.616

5.  Peritoneal absorption of pancreatic enzymes in bile-induced acute pancreatitis in dogs.

Authors:  Y Sugimoto; T Hayakawa; T Kondo; T Shibata; W Kishimoto
Journal:  J Gastroenterol Hepatol       Date:  1990 Sep-Oct       Impact factor: 4.029

6.  Stimulatory effects of bombesin on plasma trypsin release and exocrine pancreatic secretion in dogs.

Authors:  S Kiriyama; T Hayakawa; T Kondo; T Shibata; M Kitagawa; Y Sakai; H Sobajima; N Ikei; T Kodaira; T Hamaoka
Journal:  Digestion       Date:  1990       Impact factor: 3.216

7.  Experimental pancreatolithiasis in the dog.

Authors:  K Konishi; R Izumi; O Kato; A Yamaguchi; I Miyazaki
Journal:  Surgery       Date:  1981-06       Impact factor: 3.982

8.  Ultrastructural changes in the exocrine pancreas of experimental pancreatolithiasis in dogs.

Authors:  A Sakakibara; N Okumura; T Hayakawa; M Kanzaki
Journal:  Am J Gastroenterol       Date:  1982-07       Impact factor: 10.864

9.  Plasma pancreatic glucagon response to blood glucose in experimental pancreatolithiasis in dogs.

Authors:  N Okumura; T Hayakawa; A Sakakibara; A Noda; T Kondo
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

10.  Impaired pancreatic polypeptide release in chronic pancreatitis with steatorrhoea.

Authors:  T E Adrian; H S Besterman; C N Mallinson; C Garalotis; S R Bloom
Journal:  Gut       Date:  1979-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.